Maynard Um
-
-
-
-
-
-
-
Aethlon Medical reports preliminary data from cancer device trial
-
-
-
-
-
-
-
Biotech and Medical Tech Stocks Report Significant Updates in the Race for Cancer Treatments as Cancer Rates Rise Globally
-
-
-
-
-
-
-
Aethlon Medical (AEMD) Announces Publication of Preclinical Data Showing Ability of the Hemopurifier to Remove Extracellular Vesicles and microRNAs from Renal Perfusates Following Controlled Oxygenate
-
-
-
-
-
404,872 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

